Anticonvulsant potential of the phytocannabinoid, cannabidivarin, on epilepsy disease progression
Epilepsy affects about 0.8% of individuals [1]. Many treatments are available but more effective and better-tolerated antiepileptic drugs (AEDs) with new mechanisms of actions (MOAs) are needed [2, 3]. Cannabis has been historically used to treat epilepsy [4]. In our laboratory, we have demonstrated...
| Main Author: | |
|---|---|
| Published: |
University of Reading
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.657606 |